arrow_back Trending Legislation
Share share

More Data on Addiction Treatment: New State Requirements

New regulations require states to collect and report detailed data on addiction treatment, including available medications and protocols to prevent misuse. This aims to improve program effectiveness and patient safety, potentially impacting the quality of healthcare for individuals struggling with addiction.
Key points
States must describe types of medication-assisted treatment drugs available.
Protocols for preventing diversion and misuse of these medications will be required.
States will need to collect data on misuse, including mixing with other prescription drugs.
Drug screening protocols for patients receiving medication-assisted treatment will be mandated.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
Print number: HR 5630
Sponsor: Rep. Houchin, Erin [R-IN-9]
Process start date: 2025-09-30
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about More Data on Addiction Treatment: New State Requirements

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 5630.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-30.

What are the main provisions?

Key points include:

  • States must describe types of medication-assisted treatment drugs available.
  • Protocols for preventing diversion and misuse of these medications will be required.
  • States will need to collect data on misuse, including mixing with other prescription drugs.
  • Drug screening protocols for patients receiving medication-assisted treatment will be mandated.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Houchin, Erin [R-IN-9].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

Analysis and Potential Impact of HR 5630

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health